Marijuana use is associated with HPV-positive head and neck squamous cell carcinoma (HNSCC).
However, cannabinoid use continues to increase in the US general population for recreational purposes as well as in cancer patients for palliative care.
In this study, we explored the role of cannabidiol (CBD) in promoting anti-tumor activity by modulating immune response in HPV-positive HNSCC by using pre-clinical models.
